Hyloris Pharmaceuticals SA (HYL)
Market Open
10 Aug, 15:30
XBRU 
€
4. 53
-0.03
-0.6579%
€
142.8M Market Cap
- P/E Ratio
- Div Yield
81 Volume
0 Eps
€ 4.56
Previous Close Want to track HYL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hyloris Pharmaceuticals SA (HYL) Statistics
Valuation metrics
Market Cap 142.8M
Enterprise value 132.1M
Trailing P/E (ttm) -22.17
Forward P/E 10.33
PEG ratio 10.33
Price/Sales (ttm) 16.55
Price/Book (mrq) 5.47
Enterprise Value/Revenue 14.96
Enterprise Value/EBITDA -19.46
Overview
Shares outstanding 28M
Float 11.36M
Shares short -
% Held by insiders 0.58%
% Held by institutions 0%
Average volume (10 days) 3.14K
Average volume (90 days) 6.52K
Price summary
52-Week low 4.2
52-Week high 8.4
Beta 0.65
50-Day moving average 5.42
200-Day moving average 6.2
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Jun 2020
Profitability
Profit margin -0.72%
Operating margin -0.76%
Operational effectiveness
Return on assets -0.13%
Return on equity -0.22%
Income Statement
Revenue (ttm) 8.83M
Revenue per share (ttm) 0.32
Quarterly revenue growth (yoy) 0.07%
Gross profit (ttm) 8.45M
EBITDA -6.79M
Net income to common (ttm) -6.33M
Diluted EPS (ttm) -0.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 14.27M
Total cash per share (mrq) 0.51
Total debt (mrq) 1.61M
Total Debt/Equity (mrq) 6.08
Current ratio (mrq) 3.89%
Book value per share (mrq) 0.95
Cash Flow
Cash flow statement -6.99M
Levered free cash flow (LFCF) -6.53M
